drugset / Trial / NCT01195753

Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders

NCT01195753 ↗

Phase 2 Terminated 10 enrolled Cytonet GmbH & Co. KG
NaSingle-groupOpen-labelTreatment

Summary

Treatment with liver cell infusion for children with urea cycle disorders (UCD).

Timeline

Start
2010-12
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject HHLivC Cell therapy — —

Indications